Procore Technologies Valuation
Is PCOR * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PCOR * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PCOR * (MX$1173.3) is trading below our estimate of fair value (MX$1247)
Significantly Below Fair Value: PCOR * is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PCOR *?
Other financial metrics that can be useful for relative valuation.
What is PCOR *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$9.36b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 8.6x |
Enterprise Value/EBITDA | -71x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does PCOR *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 10.8x | ||
APPF AppFolio | 12.9x | 17.3% | US$8.4b |
CFLT Confluent | 10.5x | 17.7% | US$8.7b |
ESTC Elastic | 8.7x | 15.7% | US$11.1b |
HCP HashiCorp | 11.1x | 13.5% | US$6.7b |
PCOR * Procore Technologies | 9.3x | 16.0% | Mex$9.4b |
Price-To-Sales vs Peers: PCOR * is good value based on its Price-To-Sales Ratio (9.3x) compared to the peer average (10.7x).
Price to Earnings Ratio vs Industry
How does PCOR *'s PE Ratio compare vs other companies in the Global Software Industry?
Price-To-Sales vs Industry: PCOR * is expensive based on its Price-To-Sales Ratio (9.3x) compared to the Global Software industry average (2.9x).
Price to Sales Ratio vs Fair Ratio
What is PCOR *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 9.3x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate PCOR *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | Mex$1,471.43 0% | 8.7% | Mex$1,670.95 | Mex$1,257.70 | n/a | 17 |
Jun ’25 | Mex$1,173.30 | Mex$1,390.12 +18.5% | 7.6% | Mex$1,561.09 | Mex$1,208.58 | n/a | 15 |
May ’25 | Mex$1,184.30 | Mex$1,483.88 +25.3% | 7.2% | Mex$1,622.04 | Mex$1,280.56 | n/a | 15 |
Apr ’25 | n/a | Mex$1,455.27 0% | 6.9% | Mex$1,584.70 | Mex$1,251.08 | n/a | 15 |
Mar ’25 | n/a | Mex$1,465.34 0% | 8.5% | Mex$1,619.94 | Mex$1,193.64 | n/a | 15 |
Feb ’25 | n/a | Mex$1,270.89 0% | 10.9% | Mex$1,424.17 | Mex$857.94 | n/a | 15 |
Jan ’25 | n/a | Mex$1,178.82 0% | 11.3% | Mex$1,376.72 | Mex$860.45 | n/a | 14 |
Dec ’24 | n/a | Mex$1,154.17 0% | 10.5% | Mex$1,300.89 | Mex$855.85 | n/a | 14 |
Nov ’24 | n/a | Mex$1,505.71 0% | 5.7% | Mex$1,635.16 | Mex$1,271.79 | n/a | 16 |
Oct ’24 | n/a | Mex$1,431.67 0% | 5.8% | Mex$1,551.17 | Mex$1,206.46 | n/a | 15 |
Sep ’24 | n/a | Mex$1,418.65 0% | 4.8% | Mex$1,530.92 | Mex$1,275.77 | n/a | 15 |
Aug ’24 | n/a | Mex$1,326.17 0% | 7.8% | Mex$1,501.33 | Mex$1,117.65 | n/a | 14 |
Jul ’24 | n/a | Mex$1,287.00 0% | 6.2% | Mex$1,459.99 | Mex$1,150.82 | n/a | 14 |
Jun ’24 | n/a | Mex$1,338.00 0% | 6.3% | Mex$1,522.20 | Mex$1,199.85 | Mex$1,173.30 | 14 |
May ’24 | n/a | Mex$1,360.09 0% | 7.5% | Mex$1,530.45 | Mex$1,134.33 | Mex$1,184.30 | 13 |
Apr ’24 | n/a | Mex$1,387.72 0% | 8.1% | Mex$1,549.93 | Mex$1,135.41 | n/a | 13 |
Mar ’24 | n/a | Mex$1,407.76 0% | 8.3% | Mex$1,578.61 | Mex$1,156.42 | n/a | 13 |
Feb ’24 | Mex$901.14 | Mex$1,241.10 +37.7% | 9.7% | Mex$1,394.79 | Mex$1,036.67 | n/a | 13 |
Jan ’24 | Mex$901.14 | Mex$1,313.70 +45.8% | 8.8% | Mex$1,447.63 | Mex$1,075.94 | n/a | 13 |
Dec ’23 | n/a | Mex$1,310.40 0% | 9.1% | Mex$1,449.11 | Mex$1,077.04 | n/a | 12 |
Nov ’23 | n/a | Mex$1,345.73 0% | 9.7% | Mex$1,585.15 | Mex$1,089.79 | n/a | 12 |
Oct ’23 | n/a | Mex$1,469.71 0% | 9.4% | Mex$1,771.70 | Mex$1,268.38 | n/a | 11 |
Sep ’23 | n/a | Mex$1,491.35 0% | 9.7% | Mex$1,790.43 | Mex$1,281.79 | n/a | 10 |
Aug ’23 | n/a | Mex$1,453.28 0% | 16.7% | Mex$1,944.54 | Mex$1,166.72 | n/a | 10 |
Jul ’23 | n/a | Mex$1,550.82 0% | 13.2% | Mex$1,923.34 | Mex$1,275.48 | n/a | 10 |
Jun ’23 | n/a | Mex$1,630.51 0% | 17.6% | Mex$2,244.44 | Mex$1,350.64 | n/a | 11 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.